Af­ter PhII re­sults dis­ap­point, Mer­ck ex­cis­es eye drugs from long­time pact with NGM

Mer­ck is drop­ping a slate of ex­per­i­men­tal eye drugs from its part­ner­ship with NGM Bio, mark­ing an­oth­er dead end for their sev­en-year al­liance.

The de­ci­sion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER